Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Advancing new possibilities for research

“As a leader in genome editing, our new technology is just one example of our commitment to solving challenges in the genome editing field, and we will continue to make CRISPR research a priority.”
Udit Batra, Member of the Executive Board and CEO Life Science

Our tools for CRISPR technology

Advances in genome editing using “DNA scissors” such as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) help to more quickly discover and produce new therapeutic options for conditions that are difficult to treat. Researchers are working, for example, to identify genes that are associated with cancer. The vision is to disable or change the specific genes using DNA scissors.
We want to equip researchers and scientists with the necessary solutions to develop new approaches for better healthcare. For faster drug discovery and for the biopharmaceutical production of genetically modified cell therapies, Merck produces innovative tools for genome editing and customized cell lines. This primarily includes functional genetic reagents and CRISPR libraries to screen genes and to knock out gene functions.
For over 14 years, our company has been active in the field of genome editing and strives to meet the growing need for genetically based therapeutics by continuously developing groundbreaking technologies. Our latest method “proxy-CRISPR”, which is now being introduced to the market, makes genome editing even more efficient, more flexible and more specific, enabling access to genomic regions that have so far been unreachable using conventional tools.


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.